The case against evidence-based principles in psychiatry

Medical Hypotheses

Volumn 67, Issue 2, 2006, Pages 401-410

  Levine, Robert ^a   Fink, Max ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; CLOZAPINE; FLUOXETINE; LAMOTRIGINE; LITHIUM CARBONATE; NEUROLEPTIC AGENT; OLANZAPINE; PLACEBO; QUETIAPINE; RISPERIDONE; SERTRALINE; TRANQUILIZER; ZIPRASIDONE;

AFFECTIVE PSYCHOSIS; ALTERNATIVE MEDICINE; ARTICLE; ASPERGER SYNDROME; BIPOLAR DISORDER; CATATONIA; CLINICAL PRACTICE; CLINICAL TRIAL; COMORBIDITY; CONSULTATION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; ELECTROCONVULSIVE THERAPY; EVIDENCE BASED MEDICINE; FINANCIAL MANAGEMENT; GENETIC SUSCEPTIBILITY; HALLUCINATION; HEALTH INSURANCE; HUMAN; LOW DRUG DOSE; MAJOR DEPRESSION; MANIA; MELANCHOLIA; MENTAL DISEASE; OBSESSIVE COMPULSIVE DISORDER; PATENT; PATIENT SELECTION; PRIORITY JOURNAL; PSYCHOSIS; RATING SCALE; REIMBURSEMENT; REMISSION; SCHIZOAFFECTIVE PSYCHOSIS; SYMPTOMATOLOGY; TREATMENT OUTCOME; VALIDITY;

EVIDENCE-BASED MEDICINE; HUMANS; MENTAL DISORDERS; PRACTICE GUIDELINES; PSYCHIATRY; REPRODUCIBILITY OF RESULTS; UNITED STATES;

EID: 33744725247     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.02.025     Document Type: Article

References (51)

1. Carpinello SE, Rosenbeg L, Stone J, Schwager M, Felton CJ. New York State's campaign to implement evidence-based practices for people with serious mental disorders, http://www.omh.state.ny.us/.omhweb/omhq/q0302/Implement EBP.htm; 2006 [accessed 4.02.06].
2. Sackett D.L., Rosenberg W.M.C., Gray J.A.M., Haynes R.B., and Richardson W.S. Evidence-based medicine: what it is and what it isn't. BMJ 312 (1996) 71-72
3. Sackett D.L., Strauss S.E., Richardson W.S., Rosenberg W., and Haynes R.B. Evidence-based medicine: how to practice and teach EBM. second ed. (2000), Churchill Livingston, New York
4. Gray G.E. The philosophy and methods of evidence-based medicine: an introduction for psychiatrists. Directions in Psychiatry 22 (2002) 165-173
5. Kopelman M.D., and Fleminger S. Experiences and perspectives on the classification of organic mental disorders. Psychopathology 35 (2002) 76-81
6. Taylor M.A., and Vaidya N. Psychopathology in neuropsychiatry: DSM and beyond. J Neuropsychiatry Clin Neurosci 17 (2005) 246-249
7. Klein D.F. The pharmacological validation of psychiatric diagnosis. In: Klein D.F., Robins L.N., and Barrett J.E. (Eds). The validity of psychiatric diagnosis (1989), Raven Press, New York 177-201
8. Fink M. Should the dexamethasone suppression test be resurrected?. Acta Psychiatrica Scandinavica 112 (2005) 245-249
9. Arana G.W., Baldessarini R.J., and Ornsteen M. The dexamethasone suppression test for diagnosis and prognosis in psychiatry. Arch Gen Psychiatry 42 (1985) 1193-1204
10. Chen Y.R., Swann A.C., and Johnson B.A. Stability of diagnosis in bipolar disorder. J Nerv Ment Dis 186 (1998) 17-23
11. Möller H.J. Bipolar disorder and schizophrenia: distinct illnesses or continuum. J Clin Psychiatry 64 6 (2003) 23-27
12. Schurhoff F., Szoke A., Meary A., Bellivier F., Rouillon F., Pauls D., et al. Familial aggregation of delusional proneness in schizophrenia and bipolar pedigrees. Am J Psychiatry 160 (2003) 1313-1319
13. Maier W., Lichtermann D., Minges J., Hallmayer J., Heun R., Benkert O., et al. Continuity and discontinuity of affective disorders and schizophrenia. Results of a controlled family study. Arch Gen Psychiatry 50 (1993) 871-883
14. Rende R., Hodgins S., Palmour R., Faucher B., and Allaire J.F. Familial overlap between bipolar disorder and psychotic symptoms in a Canadian cohort. Can J Psychiatry 50 (2004) 189-194
15. Kendell R.E. The major functional psyches: are they independent entities or part of a continuum?. In: Kerr A., and McCllelland H. (Eds). Concepts of mental disorder (1991), Gaskell, London 1-16
16. Williams D.D.R., and Garner J. The case against "the evidence": a different perspective on evidence-based medicine. Br J Psychiatry 180 (2002) 8-12
17. Weinberger D.R., Egan M.F., Bertolino A., Callicott J.H., Mattay V.S., Lipska B.K., et al. Prefrontal neurons and the genetics of schizophrenia. Biol Psychiatry 50 (2001) 825-844
18. Goldberg T.E., Egan M.F., Gscheidle T., Coppola R., Weickert T., Kolacana B.S., et al. Executive in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia. Arch Gen Psychiatry 60 (2003) 889-896
19. Weickert C.S., Straub R.E., McClintock B.W., Matsumoto M., Hashimoto R., Hyde T.M., et al. Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain. Arch Gen Psychiatry 61 6 (2004) 544-555
20. Numakawa T., Yagasaki Y., Ishimoto T., et al. Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia. Hum Mol Genet (England) 13 (2004) 2699-2708
21. Burt S.A., Krueger R.F., McGue M., and Iacono W. Parent-child conflict and the comorbidity among childhood externalizing disorders. Arch Gen Psychiatry 60 (2003) 505-513
22. Maughan B., Rowe R., Messer J., Goodman R., and Meltzer H. Conduct disorder and oppositional defiant disorder in a national sample: developmental epidemiology. J Child Psychol Psychiatry 45 (2004) 609-621
23. Thapar A., Harrington R., and McGuffin P. Examining the comorbidity of ADHD-related behaviours and conduct problems using a twin study design. Br J Psychiatry 179 (2001) 224-229
24. Cassano G.B., Pini S., Saettoni M., and Dell'Osso L. Multiple anxiety disorder comorbidity in patients with mood spectrum disorders with psychotic features. Am J Psychiatry 156 (1999) 474-476
25. Katerndahl D.A., and Realini J.P. Comorbid psychiatric disorders in subjects with panic attacks. J Nerv Ment Dis 185 (1997) 669-674
26. Richter M.A., Summerfeldt L.J., Antony M.M., and Swinson R.P. Obsessive-compulsive spectrum conditions in obsessive-compulsive disorder and other anxiety disorders. Depress Anxiety 18 (2003) 118-127
27. Sanderson W.C., DiNardo P.A., Rapee R.M., and Barlow D.H. Syndrome comorbidity in patients diagnosed with a DSM-III-R anxiety disorder. J Abnorm Psychol 99 (1990) 308-312
28. Freeeman M.P., Freeman S.A., and Mc Elroy S.L. The comorbidity of bipolar and anxiety states: prevalence, psychobiology, and treatment issues. J Affect Disord 78 (2004) 175-183
29. Rihmer Z., Barsi J., Belso N., Pestality P., and Gyorgy S. Antidepresssant induced hypomania in obsessive-compulsive disorder. Int Clin Psychopharmacol 11 (1996) 203-205
30. Weickert T.W., Goldberg T.E., Mishara A., Apud J.A., Kolachana B.S., Egan M.F., et al. Catechol-O-methyltransferase val108/158met genotype predicts working memory response to antipsychotic medications. Biol Psychiatry 56 (2004) 677-682
31. Taylor M.A., and Fink M. Catatonia in psychiatric classification: a home of its own. Am J Psychiatry 160 (2003) 1233-1241
32. Fink M., and Taylor M.A. Catatonia: a clinician's guide to diagnosis and treatment (2003), Cambridge University Press, Cambridge, UK
33. Parker G., and Hadzi-Pavlovic D. Melancholia: a disorder of movement and mood (1996), Cambridge University Press, Cambridge, UK
34. Taylor M.A., and Fink M. Melancholia: the diagnosis, pathophysiology and treatment of depressive illness (2006), Cambridge University Press, Cambridge, UK
35. Tucker G.J. Limitations of the DSM-IV as a diagnostic tool. Directions in Psychiatry 20 (2000) 127-135
36. Widiger T.A. Personality disorders in the 21st century. J Personality Disord 14 (2000) 3-16
37. Sprock J.A. Comparative study of the dimensions and facets of the five-factor model in the diagnosis of cases of personality disorder. J Personality Disord 16 (2002) 402-423
38. Smith D.J., Muir W.J., and Blackwood D.H. Is borderline personality disorder part of the bipolar spectrum?. Harvard Rev Psychiatry 12 (2004) 133-139
39. Shapiro A.K., and Shapiro E. The powerful placebo (1997), Johns Hopkins University Press, Baltimore, London
40. Khan A., and Schwatz K. Study designs and outcomes in antidepressant clinical trials. Essential Psychopharmacol 6 (2005) 221-226
41. Vedamtan S. Drugmakers prefer silence on test data. Washington Post July 9 (2004)
42. Sussman N. Misuse of evidence: an open secret. Primary Psychiatry 10 9 (2003) 14
43. Lexchin J., Bero L.A., Djulbegovic B., and Clark O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 326 7400 (2003) 1167-1170
44. Williams D.D.R., and Garner J. The case against "the evidence": a different perspective on evidence-based medicine. Br J Psychiatry 180 (2002) 8-12
45. Bauer M.S. How solid is the evidence for the efficacy of mood stabilizers in bipolar disorder?. Directions in Psychiatry 25 (2005) 165-181
46. Weinberger D, Stahl SM. Genes circuits, and pharmacology: clinical connections in schizophrenia. Archived satellite presentation. NeuroScience Education Institute; July 2004.
47. Sackett D.L., Strauss S.E., Richardson W.S., Rosenberg W., and Haynes N.D. Evidence-based medicine: how to practice and teach EBM. second ed. (2000), Churchill Livingstone, New York
48. Egger M., Smith G.D., and O'Rourke K. Rationale potentials, and promise of systematic reviews. In: Egger M., Smith G.D., and Altman D.G. (Eds). Systematic reviews in health care: meta - analysis in context (2001), BMJ Books, London 3-19
49. Baker M., and Kleijnen J. The drive towards evidence-based health care. In: Rowland N., and Gross S. (Eds). Evidence-based counseling and psychological therapies: research and applications 2000 (2000), Routledge, Philadelphia 3013-3029
50. Reynolds S. The anatomy of evidence-based practice: principles and methods. In: Trinder L., and Reynolds S. (Eds). Evidence-based practice: a critical appraisal (2000), Blackwell Science, Malden, MA
51. Wong K. Alternative Medicine, http://altmedicine. about.com/od/alternativemedicinebasics/a/Insurance.htm; 2006 [accessed 4.02.06].